US Pharm. 2015;40(6):HS-42.
Biomedical researchers at Cedars-Sinai Medical Center in Los Angeles have invented a tiny drug-delivery system that can identify cancer cell types in the brain through “virtual biopsies” and then attack the molecular structure of the disease.
If laboratory research with mice is borne out in human studies, the results could be used to deliver nano-scale drugs that can fight tumor cells in the brain without surgery.
“Our nanodrug can be engineered to carry a variety of drugs, proteins and genetic materials to attack tumors on several fronts from within the brain,” said Julia Ljubimova, MD, PhD, professor of neurosurgery and biomedical sciences at Cedars-Sinai and a lead author of an online article in the American Chemical Society’s journal ACS Nano.
